Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Andrew Bruce Onderdonk, Ph.D.

TitleProfessor of Pathology
InstitutionBrigham and Women's Hospital
DepartmentPathology
AddressChanning Laboratory
Pathology
180 Longwood Ave
Boston MA 02115
Phone617/525-2506
Fax617/525-2500

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Zilber AL, Picardeau M, Ayral F, Artois M, Demont P, Kodjo A, Djelouadji Z, Onderdonk AB. High-Resolution Typing of Leptospira interrogans Strains by Multispacer Sequence Typing. J Clin Microbiol. 2014 Feb; 52(2):564-71.
    View in: PubMed
  2. Wang X, Seo DJ, Lee MH, Choi C, Onderdonk AB. Comparison of conventional PCR, multiplex PCR, and loop-mediated isothermal amplification assays for rapid detection of arcobacter species. J Clin Microbiol. 2014 Feb; 52(2):557-63.
    View in: PubMed
  3. Klima CL, Zaheer R, Cook SR, Booker CW, Hendrick S, Alexander TW, McAllister TA, Onderdonk AB. Pathogens of Bovine Respiratory Disease in North American Feedlots Conferring Multidrug Resistance via Integrative Conjugative Elements. J Clin Microbiol. 2014 Feb; 52(2):438-48.
    View in: PubMed
  4. Fichorova RN, Buck OR, Yamamoto HS, Fashemi T, Dawood HY, Fashemi B, Hayes GR, Beach DH, Takagi Y, Delaney ML, Nibert ML, Singh BN, Onderdonk AB. The Villain Team-Up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect. 2013 Sep; 89(6):460-6.
    View in: PubMed
  5. Kapalschinski N, Seipp HM, Onderdonk AB, Goertz O, Daigeler A, Lahmer A, Lehnhardt M, Hirsch T. Albumin reduces the antibacterial activity of polyhexanide-biguanide-based antiseptics against Staphylococcus aureus and MRSA. Burns. 2013 Sep; 39(6):1221-5.
    View in: PubMed
  6. Fashemi B, Delaney ML, Onderdonk AB, Fichorova RN. Effects of feminine hygiene products on the vaginal mucosal biome. Microb Ecol Health Dis. 2013; 24.
    View in: PubMed
  7. Chen L, Chen Z, Baker K, Halvorsen EM, Pires da Cunha A, Flak MB, Gerber G, Huang YH, Hosomi S, Arthur JC, Dery KJ, Nagaishi T, Beauchemin N, Holmes KV, Ho JW, Shively JE, Jobin C, Onderdonk AB, Bry L, Weiner HL, Higgins DE, Blumberg RS. The Short Isoform of the CEACAM1 Receptor in Intestinal T Cells Regulates Mucosal Immunity and Homeostasis via Tfh Cell Induction. Immunity. 2012 Nov 16; 37(5):930-46.
    View in: PubMed
  8. Gerber GK, Onderdonk AB, Bry L. Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol. 2012; 8(8):e1002624.
    View in: PubMed
  9. Lange NE, Celedón JC, Forno E, Ly NP, Onderdonk A, Bry L, Delaney ML, DuBois AM, Gold DR, Weiss ST, Litonjua AA. Maternal intestinal flora and wheeze in early childhood. Clin Exp Allergy. 2012 Jun; 42(6):901-8.
    View in: PubMed
  10. Kelley JM, Onderdonk AB, Kao G. Bacillus cereus septicemia attributed to a matched unrelated bone marrow transplant. Transfusion. 2013 Feb; 53(2):394-7.
    View in: PubMed
  11. Barczak AK, Gomez JE, Kaufmann BB, Hinson ER, Cosimi L, Borowsky ML, Onderdonk AB, Stanley SA, Kaur D, Bryant KF, Knipe DM, Sloutsky A, Hung DT. RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities. Proc Natl Acad Sci U S A. 2012 Apr 17; 109(16):6217-22.
    View in: PubMed
  12. Roberts DJ, Celi AC, Riley LE, Onderdonk AB, Boyd TK, Johnson LC, Lieberman E. Acute histologic chorioamnionitis at term: nearly always noninfectious. PLoS One. 2012; 7(3):e31819.
    View in: PubMed
  13. Helderman JB, O'Shea TM, Kuban KC, Allred EN, Hecht JL, Dammann O, Paneth N, McElrath TF, Onderdonk A, Leviton A. Antenatal antecedents of cognitive impairment at 24 months in extremely low gestational age newborns. Pediatrics. 2012 Mar; 129(3):494-502.
    View in: PubMed
  14. Trivedi S, Joachim M, McElrath T, Kliman HJ, Allred EN, Fichorova RN, Onderdonk A, Heitor F, Chaychi L, Leviton A, Majzoub JA. Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Am J Obstet Gynecol. 2012 Mar; 206(3):236.e1-8.
    View in: PubMed
  15. Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB, Doncel GF. Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio. 2011; 2(6):e00168-11.
    View in: PubMed
  16. Chen ML, Allred EN, Hecht JL, Onderdonk A, VanderVeen D, Wallace DK, Leviton A, Dammann O. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2011 Sep; 52(10):7052-8.
    View in: PubMed
  17. Chalabaev S, Anderson CA, Onderdonk AB, Kasper DL. Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. J Microbiol Methods. 2011 Jun; 85(3):230-2.
    View in: PubMed
  18. Riley LE, Celi AC, Onderdonk AB, Roberts DJ, Johnson LC, Tsen LC, Leffert L, Pian-Smith MC, Heffner LJ, Haas ST, Lieberman ES. Association of epidural-related fever and noninfectious inflammation in term labor. Obstet Gynecol. 2011 Mar; 117(3):588-95.
    View in: PubMed
  19. Johnson JA, Onderdonk AB, Cosimi LA, Yawetz S, Lasker BA, Bolcen SJ, Brown JM, Marty FM. Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature. J Clin Microbiol. 2011 Apr; 49(4):1662-6.
    View in: PubMed
  20. Fichorova RN, Onderdonk AB, Yamamoto H, Delaney ML, DuBois AM, Allred E, Leviton A. Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio. 2011; 2(1):e00280-10.
    View in: PubMed
  21. Patterson HC, Sturtevant O, Schott D, Alyea EP, Onderdonk AB, Kao GS. Isolation of non-typhoidal Salmonella from a haematopoietic progenitor cell product. Transfus Med. 2010 Dec; 20(6):424-5.
    View in: PubMed
  22. Genc MR, Onderdonk A. Endogenous bacterial flora in pregnant women and the influence of maternal genetic variation. BJOG. 2011 Jan; 118(2):154-63.
    View in: PubMed
  23. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, Khlebnikov A, van Hylckama Vlieg JE, Punit S, Glickman JN, Onderdonk A, Glimcher LH, Garrett WS. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A. 2010 Oct 19; 107(42):18132-7.
    View in: PubMed
  24. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN, Gordon JI, Onderdonk AB, Glimcher LH. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010 Sep 16; 8(3):292-300.
    View in: PubMed
  25. Parsonnet J, Hansmann MA, Seymour JL, Delaney ML, Dubois AM, Modern PA, Jones MB, Wild JE, Onderdonk AB. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women. BMC Infect Dis. 2010; 10:249.
    View in: PubMed
  26. Leviton A, Kuban K, Allred EN, Hecht JL, Onderdonk A, O'Shea TM, McElrath T, Paneth N. Antenatal antecedents of a small head circumference at age 24-months post-term equivalent in a sample of infants born before the 28th post-menstrual week. Early Hum Dev. 2010 Aug; 86(8):515-21.
    View in: PubMed
  27. McElrath TF, Allred EN, Kuban K, Hecht JL, Onderdonk A, O'Shea TM, Paneth N, Leviton A. Factors associated with small head circumference at birth among infants born before the 28th week. Am J Obstet Gynecol. 2010 Aug; 203(2):138.e1-8.
    View in: PubMed
  28. Peterson LR, Liesenfeld O, Woods CW, Allen SD, Pombo D, Patel PA, Mehta MS, Nicholson B, Fuller D, Onderdonk A. Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs. J Clin Microbiol. 2010 May; 48(5):1661-6.
    View in: PubMed
  29. Leviton A, Allred EN, Kuban KC, Hecht JL, Onderdonk AB, O'shea TM, Paneth N. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study. Pediatr Res. 2010 Jan; 67(1):95-101.
    View in: PubMed
  30. Nieuwenhuis EE, Matsumoto T, Lindenbergh D, Willemsen R, Kaser A, Simons-Oosterhuis Y, Brugman S, Yamaguchi K, Ishikawa H, Aiba Y, Koga Y, Samsom JN, Oshima K, Kikuchi M, Escher JC, Hattori M, Onderdonk AB, Blumberg RS. Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest. 2009 May; 119(5):1241-50.
    View in: PubMed
  31. Hirsch T, Spielmann M, Zuhaili B, Fossum M, Metzig M, Koehler T, Steinau HU, Yao F, Onderdonk AB, Steinstraesser L, Eriksson E. Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med. 2009 Mar; 11(3):220-8.
    View in: PubMed
  32. Forno E, Onderdonk AB, McCracken J, Litonjua AA, Laskey D, Delaney ML, Dubois AM, Gold DR, Ryan LM, Weiss ST, Celedón JC. Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy. 2008; 6:11.
    View in: PubMed
  33. McElrath TF, Hecht JL, Dammann O, Boggess K, Onderdonk A, Markenson G, Harper M, Delpapa E, Allred EN, Leviton A. Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol. 2008 Nov 1; 168(9):980-9.
    View in: PubMed
  34. Goodman ER, Platt R, Bass R, Onderdonk AB, Yokoe DS, Huang SS. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol. 2008 Jul; 29(7):593-9.
    View in: PubMed
  35. Huang SS, Diekema DJ, Warren DK, Zuccotti G, Winokur PL, Tendolkar S, Boyken L, Datta R, Jones RM, Ward MA, Aubrey T, Onderdonk AB, Garcia C, Platt R. Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis. 2008 Apr 15; 46(8):1241-7.
    View in: PubMed
  36. Onderdonk AB, Hecht JL, McElrath TF, Delaney ML, Allred EN, Leviton A. Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol. 2008 Jul; 199(1):52.e1-52.e10.
    View in: PubMed
  37. Hirsch T, Spielmann M, Zuhaili B, Koehler T, Fossum M, Steinau HU, Yao F, Steinstraesser L, Onderdonk AB, Eriksson E. Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg. 2008; 8:5.
    View in: PubMed
  38. Maung AA, Fujimi S, MacConmara MP, Tajima G, McKenna AM, Delisle AJ, Stallwood C, Onderdonk AB, Mannick JA, Lederer JA. Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J Immunol. 2008 Feb 15; 180(4):2450-8.
    View in: PubMed
  39. Hecht JL, Onderdonk A, Delaney M, Allred EN, Kliman HJ, Zambrano E, Pflueger SM, Livasy CA, Bhan I, Leviton A. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol. 2008 Jan-Feb; 11(1):15-22.
    View in: PubMed
  40. Onderdonk AB, Delaney ML, DuBois AM, Allred EN, Leviton A. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol. 2008 Jan; 198(1):110.e1-7.
    View in: PubMed
  41. Reilly N, Poylin V, Menconi M, Onderdonk A, Bengmark S, Hasselgren PO. Probiotics potentiate IL-6 production in IL-1beta-treated Caco-2 cells through a heat shock-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2007 Sep; 293(3):R1169-79.
    View in: PubMed
  42. Genç MR, Vardhana S, Delaney ML, Witkin SS, Onderdonk AB. TNFA-308G>A polymorphism influences the TNF-alpha response to altered vaginal flora. Eur J Obstet Gynecol Reprod Biol. 2007 Oct; 134(2):188-91.
    View in: PubMed
  43. Ly NP, Ruiz-Pérez B, Onderdonk AB, Tzianabos AO, Litonjua AA, Liang C, Laskey D, Delaney ML, DuBois AM, Levy H, Gold DR, Ryan LM, Weiss ST, Celedón JC. Mode of delivery and cord blood cytokines: a birth cohort study. Clin Mol Allergy. 2006; 4:13.
    View in: PubMed
  44. Genç MR, Delaney ML, Onderdonk AB, Witkin SS. Vaginal nitric oxide in pregnant women with bacterial vaginosis. Am J Reprod Immunol. 2006 Aug; 56(2):86-90.
    View in: PubMed
  45. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use. J Clin Gastroenterol. 2006 Mar; 40(3):275-8.
    View in: PubMed
  46. Onderdonk AB. Probiotics for women's health. J Clin Gastroenterol. 2006 Mar; 40(3):256-9.
    View in: PubMed
  47. Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol. 2005 Sep; 43(9):4628-34.
    View in: PubMed
  48. Chen KT, Puopolo KM, Eichenwald EC, Onderdonk AB, Lieberman E. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol. 2005 Apr; 192(4):1167-71.
    View in: PubMed
  49. Genç MR, Karasahin E, Onderdonk AB, Bongiovanni AM, Delaney ML, Witkin SS. Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women. Am J Obstet Gynecol. 2005 Mar; 192(3):916-21.
    View in: PubMed
  50. Onderdonk AB. Animal models simulating anaerobic infections. Anaerobe. 2005 Aug; 11(4):189-95.
    View in: PubMed
  51. Jenkins DJ, Kendall CW, Hamidi M, Vidgen E, Faulkner D, Parker T, Irani N, Wolever TM, Fong I, Kopplin P, Connelly PW, Onderdonk A, Rao AV. Effect of antibiotics as cholesterol-lowering agents. Metabolism. 2005 Jan; 54(1):103-12.
    View in: PubMed
  52. Warner JE, Onderdonk AB. Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates. Appl Environ Microbiol. 2004 Nov; 70(11):6931-5.
    View in: PubMed
  53. Genc MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E, Witkin SS. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15; 116(2):152-6.
    View in: PubMed
  54. Genc MR, Onderdonk AB, Vardhana S, Delaney ML, Norwitz ER, Tuomala RE, Paraskevas LR, Witkin SS. Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol. 2004 Oct; 191(4):1324-30.
    View in: PubMed
  55. Nguyen DP, Genc M, Vardhana S, Babula O, Onderdonk A, Witkin SS. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol. 2004 Aug; 104(2):293-300.
    View in: PubMed
  56. Mikamo H, Johri AK, Paoletti LC, Madoff LC, Onderdonk AB. Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci. Infect Immun. 2004 Aug; 72(8):4716-22.
    View in: PubMed
  57. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis. 2004 Jul 1; 190(1):202-9.
    View in: PubMed
  58. Genc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER, Onderdonk AB. A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstet Gynecol. 2004 May; 190(5):1191-7.
    View in: PubMed
  59. Hasenbein ME, Warner JE, Lambert KG, Cole SE, Onderdonk AB, McAdam AJ. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol. 2004 Apr; 42(4):1559-63.
    View in: PubMed
  60. Matsumoto T, Nieuwenhuis EE, Cisneros RL, Ruiz-Perez B, Yamaguchi K, Blumberg RS, Onderdonk AB. Protective effect of ethyl-3-(3-dimethyl aminopropyl)urea dihydrochloride (EDU) against LPS-induced death in mice. J Med Microbiol. 2004 Feb; 53(Pt 2):97-102.
    View in: PubMed
  61. Hundley AF, Onderdonk AB, Greenberg JA. Value of routine urine culture in the assessment of preterm labor. J Reprod Med. 2003 Nov; 48(11):853-7.
    View in: PubMed
  62. Ruiz-Perez B, Cisneros RL, Matsumoto T, Miller RJ, Vasios G, Calias P, Onderdonk AB. Protection against lethal intra-abdominal sepsis by 1-(3-dimethylaminopropyl)-3-ethylurea. J Infect Dis. 2003 Aug 1; 188(3):378-87.
    View in: PubMed
  63. Onderdonk AB, Lee ML, Lieberman E, Delaney ML, Tuomala RE. Quantitative microbiologic models for preterm delivery. J Clin Microbiol. 2003 Mar; 41(3):1073-9.
    View in: PubMed
  64. Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby T, Kaplan S, Kennedy D, Krug J, Levinson R, Marcus E, Metzger H, Morse SS, O'Brien A, Onderdonk A, Poste G, Renault B, Rich R, Rosengard A, Salzburg S, Scanlan M, Shenk T, Tabor H, Varmus H, Wimmer E, Yamamoto K. Statement on scientific publication and security. Science. 2003 Feb 21; 299(5610):1149.
    View in: PubMed
  65. Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby T, Kaplan S, Kennedy D, Krug J, Levinson R, Marcus E, Metzger H, Morse SS, O'Brien A, Onderdonk A, Poste G, Renault B, Rich R, Rosengard A, Salzberg S, Scanlan M, Shenk T, Tabor H, Varmus H, Wimmer E, Yamamoto K. Statement on the consideration of biodefence and biosecurity. Nature. 2003 Feb 20; 421(6925):771.
    View in: PubMed
  66. Atlas R, Campbell P, Cozzarelli NR, Curfman G, Enquist L, Fink G, Flanagin A, Fletcher J, George E, Hammes G, Heyman D, Inglesby T, Kaplan S, Kennedy D, Krug J, Levinson RE, Marcus E, Metzger H, Morse SS, O'Brien A, Onderdonk A, Poste G, Renault B, Rich R, Rosengard A, Salzberg S, Salzburg S, Scanlan M, Shenk T, Tabor H, Varmus H, Wimmer E, Yamamoto K. Uncensored exchange of scientific results. Proc Natl Acad Sci U S A. 2003 Feb 18; 100(4):1464.
    View in: PubMed
  67. Breuing K, Kaplan S, Liu P, Onderdonk AB, Eriksson E. Wound fluid bacterial levels exceed tissue bacterial counts in controlled porcine partial-thickness burn infections. Plast Reconstr Surg. 2003 Feb; 111(2):781-8.
    View in: PubMed
  68. Warner JE, Onderdonk AB. Method for optimizing pulsed-field gel electrophoresis banding pattern data. J Mol Diagn. 2003 Feb; 5(1):21-7.
    View in: PubMed
  69. Garrett AP, Wenham RM, Onderdonk AB, Sheets EE. Can Monsel's Transmit Nosocomial Infections? A Microbiological Investigation. J Low Genit Tract Dis. 2002 Oct; 6(4):228-31.
    View in: PubMed
  70. Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med. 2002 Jun; 8(6):588-93.
    View in: PubMed
  71. Delaney ML, Onderdonk AB. Nugent score related to vaginal culture in pregnant women. Obstet Gynecol. 2001 Jul; 98(1):79-84.
    View in: PubMed
  72. Ross RA, Onderdonk AB. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide. Infect Immun. 2000 Sep; 68(9):5205-9.
    View in: PubMed
  73. Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem. 2000 Mar 10; 275(10):6733-40.
    View in: PubMed
  74. Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J Immunol. 2000 Jan 15; 164(2):719-24.
    View in: PubMed
  75. Wang SJ, Kuperman GJ, Ohno-Machado L, Onderdonk A, Sandige H, Bates DW. Using electronic data to predict the probability of true bacteremia from positive blood cultures. Proc AMIA Symp. 2000; 893-7.
    View in: PubMed
  76. Tzianabos AO, Cisneros RL, Gershkovich J, Johnson J, Miller RJ, Burns JW, Onderdonk AB. Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection. Arch Surg. 1999 Nov; 134(11):1254-9.
    View in: PubMed
  77. Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC, Cywes C, Chan M, Finberg RW, Kasper DL. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol. 1999 Jul 15; 163(2):893-7.
    View in: PubMed
  78. Comstock LE, Coyne MJ, Tzianabos AO, Pantosti A, Onderdonk AB, Kasper DL. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect Immun. 1999 Jul; 67(7):3525-32.
    View in: PubMed
  79. Lee ML, DuBois A, Ross RA, Onderdonk AB. Nonlinear models for in vitro kill kinetics of antibiotics. J Biopharm Stat. 1999 May; 9(2):271-7.
    View in: PubMed
  80. Pybus V, Onderdonk AB. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect. 1999 Apr; 1(4):285-92.
    View in: PubMed
  81. Bates DW, Kuperman GJ, Rittenberg E, Teich JM, Fiskio J, Ma'luf N, Onderdonk A, Wybenga D, Winkelman J, Brennan TA, Komaroff AL, Tanasijevic M. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med. 1999 Feb; 106(2):144-50.
    View in: PubMed
  82. Onderdonk AB. Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection. Am J Surg. 1998 Dec; 176(6A Suppl):39S-45S.
    View in: PubMed
  83. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun. 1998 Dec; 66(12):6022-3.
    View in: PubMed
  84. Pybus V, Onderdonk AB. A commensal symbiosis between Prevotella bivia and Peptostreptococcus anaerobius involves amino acids: potential significance to the pathogenesis of bacterial vaginosis. FEMS Immunol Med Microbiol. 1998 Dec; 22(4):317-27.
    View in: PubMed
  85. Gibson FC, Onderdonk AB, Kasper DL, Tzianabos AO. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol. 1998 May 15; 160(10):5000-6.
    View in: PubMed
  86. Fridkin SK, Yokoe DS, Whitney CG, Onderdonk A, Hooper DC. Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol. 1998 Apr; 36(4):965-70.
    View in: PubMed
  87. Vargas SO, Horensky D, Onderdonk AB. Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A. J Clin Pathol. 1997 Dec; 50(12):996-1000.
    View in: PubMed
  88. Bates DW, Kuperman GJ, Jha A, Teich JM, Orav EJ, Ma'luf N, Onderdonk A, Pugatch R, Wybenga D, Winkelman J, Brennan TA, Komaroff AL, Tanasijevic MJ. Does the computerized display of charges affect inpatient ancillary test utilization? Arch Intern Med. 1997 Nov 24; 157(21):2501-8.
    View in: PubMed
  89. Delaney ML, Onderdonk AB. Evaluation of the AnaeroPack system for growth of clinically significant anaerobes. J Clin Microbiol. 1997 Mar; 35(3):558-62.
    View in: PubMed
  90. Pybus V, Onderdonk AB. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J Infect Dis. 1997 Feb; 175(2):406-13.
    View in: PubMed
  91. Lee ML, Ross RA, Onderdonk AB. Statistical models for vaginal microflora: identifying women at risk for group B streptococcus colonization as a test of concept. Infect Dis Obstet Gynecol. 1997; 5(5):336-40.
    View in: PubMed
  92. Katz DA, Bates DW, Rittenberg E, Onderdonk A, Sands K, Barefoot LA, Snydman D. Predicting Clostridium difficile stool cytotoxin results in hospitalized patients with diarrhea. J Gen Intern Med. 1997 Jan; 12(1):57-62.
    View in: PubMed
  93. Qu Z, Ling PR, Tahan SR, Sierra P, Onderdonk AB, Bistrian BR. Protein and lipid refeeding changes protein metabolism and colonic but not small intestinal morphology in protein-depleted rats. J Nutr. 1996 Apr; 126(4):906-12.
    View in: PubMed
  94. Gibson FC, Tzianabos AO, Onderdonk AB. The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells. Infect Immun. 1996 Mar; 64(3):1065-9.
    View in: PubMed
  95. Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest. 1995 Dec; 96(6):2727-31.
    View in: PubMed
  96. Ross RA, Lee ML, Onderdonk AB. Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol. 1995 Dec; 86(6):925-30.
    View in: PubMed
  97. Tzianabos AO, Kasper DL, Onderdonk AB. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis. 1995 Jun; 20 Suppl 2:S132-40.
    View in: PubMed
  98. Nelson D, Kuppermann N, Fleisher GR, Hammer BK, Thompson CM, Garcia CT, Novitsky TJ, Parsonnet J, Onderdonk A, Siber GR, et al. Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats. Crit Care Med. 1995 Jan; 23(1):92-8.
    View in: PubMed
  99. Tzianabos AO, Onderdonk AB, Zaleznik DF, Smith RS, Kasper DL. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect Immun. 1994 Nov; 62(11):4881-6.
    View in: PubMed
  100. Tzianabos AO, Onderdonk AB, Kasper DL. Bacterial structure and functional relation to abscess formation. Infect Agents Dis. 1994 Oct; 3(5):256-65.
    View in: PubMed
  101. Tzianabos AO, Onderdonk AB, Smith RS, Kasper DL. Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun. 1994 Aug; 62(8):3590-3.
    View in: PubMed
  102. Ross RA, Lee ML, Delaney ML, Onderdonk AB. Mixed-effect models for predicting microbial interactions in the vaginal ecosystem. J Clin Microbiol. 1994 Apr; 32(4):871-5.
    View in: PubMed
  103. McLeod RS, Antonioli D, Cullen J, Dvorak A, Onderdonk A, Silen W, Blair JE, Monahan-Earley R, Cisneros R, Cohen Z. Histologic and microbiologic features of biopsy samples from patients with normal and inflamed pouches. Dis Colon Rectum. 1994 Jan; 37(1):26-31.
    View in: PubMed
  104. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994 Jan; 169(1):127-33.
    View in: PubMed
  105. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 1993 Oct 15; 262(5132):416-9.
    View in: PubMed
  106. Pantosti A, Tzianabos AO, Reinap BG, Onderdonk AB, Kasper DL. Bacteroides fragilis strains express multiple capsular polysaccharides. J Clin Microbiol. 1993 Jul; 31(7):1850-5.
    View in: PubMed
  107. Dvorak AM, Onderdonk AB, McLeod RS, Monahan-Earley RA, Cullen J, Antonioli DA, Blair JE, Morgan ES, Cisneros RL, Estrella P, et al. Axonal necrosis of enteric autonomic nerves in continent ileal pouches. Possible implications for pathogenesis of Crohn's disease. Ann Surg. 1993 Mar; 217(3):260-71.
    View in: PubMed
  108. Dvorak AM, Onderdonk AB, McLeod RS, Monahan-Earley RA, Antonioli DA, Cullen J, Blair JE, Cisneros R, Letourneau L, Morgan E, et al. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol. 1993; 102(1):33-45.
    View in: PubMed
  109. Onderdonk AB. Methods for the isolation and identification of obligate anaerobes. Eur J Clin Microbiol Infect Dis. 1992 Nov; 11(11):1039-43.
    View in: PubMed
  110. Onderdonk AB, Delaney ML, Hinkson PL, DuBois AM. Quantitative and qualitative effects of douche preparations on vaginal microflora. Obstet Gynecol. 1992 Sep; 80(3 Pt 1):333-8.
    View in: PubMed
  111. Rodewald AK, Onderdonk AB, Warren HB, Kasper DL. Neonatal mouse model of group B streptococcal infection. J Infect Dis. 1992 Sep; 166(3):635-9.
    View in: PubMed
  112. Geshnizgani AM, Onderdonk AB. Defined medium simulating genital tract secretions for growth of vaginal microflora. J Clin Microbiol. 1992 May; 30(5):1323-6.
    View in: PubMed
  113. Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G. Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo. Infect Immun. 1992 Apr; 60(4):1642-7.
    View in: PubMed
  114. Onderdonk AB, Dvorak AM, Cisneros RL, McLeod RS, Antionoli D, Silen W, Blair JE, Monahan-Earley RA, Cullen J, Cohen Z. Microbiologic assessment of tissue biopsy samples from ileal pouch patients. J Clin Microbiol. 1992 Feb; 30(2):312-7.
    View in: PubMed
  115. Dvorak AM, McLeod RS, Onderdonk AB, Monahan-Earley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL, et al. Human gut mucosal mast cells: ultrastructural observations and anatomic variation in mast cell-nerve associations in vivo. Int Arch Allergy Immunol. 1992; 98(2):158-68.
    View in: PubMed
  116. Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol. 1992; 99(1):74-83.
    View in: PubMed
  117. Onderdonk AB. Editorial response to Brook: Comparison of in vivo methods for determination of antimicrobial efficacy. Rev Infect Dis. 1991 Nov-Dec; 13(6):1181-3.
    View in: PubMed
  118. Lindenmayer JM, Marshall D, Onderdonk AB. Dogs as sentinels for Lyme disease in Massachusetts. Am J Public Health. 1991 Nov; 81(11):1448-55.
    View in: PubMed
  119. Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun. 1991 Jun; 59(6):2075-82.
    View in: PubMed
  120. Lindenmayer J, Weber M, Bryant J, Marquez E, Onderdonk A. Comparison of indirect immunofluorescent-antibody assay, enzyme-linked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs. J Clin Microbiol. 1990 Jan; 28(1):92-6.
    View in: PubMed
  121. Delaney ML, Cisneros RL, Onderdonk AB. Comparison of in vivo and in vitro efficacy of ceftizoxime. Clin Ther. 1990; 12 Suppl C:25-30.
    View in: PubMed
  122. Onderdonk AB, Cisneros RL, Finberg R, Crabb JH, Kasper DL. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S169-77.
    View in: PubMed
  123. Crabb JH, Finberg R, Onderdonk AB, Kasper DL. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S178-84.
    View in: PubMed
  124. Onderdonk AB, Cisneros RL, Crabb JH, Finberg RW, Kasper DL. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber. Infect Immun. 1989 Oct; 57(10):3030-7.
    View in: PubMed
  125. Lindenmayer J, Weber M, Onderdonk A. Borrelia burgdorferi infection in horses. J Am Vet Med Assoc. 1989 May 15; 194(10):1384.
    View in: PubMed
  126. Kasper DL, Finberg RF, Crabb J, Onderdonk AB. Immune mechanisms in the prevention of intra-abdominal abscess formation. Scand J Infect Dis Suppl. 1989; 62:29-34.
    View in: PubMed
  127. Onderdonk AB, Delaney ML, Zamarchi GR, Hirsch ML, Munoz A, Kass EH. Normal vaginal microflora during use of various forms of catamenial protection. Rev Infect Dis. 1989 Jan-Feb; 11 Suppl 1:S61-7.
    View in: PubMed
  128. Breeling JL, Onderdonk AB, Cisneros RL, Kasper DL. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun. 1988 Jul; 56(7):1754-9.
    View in: PubMed
  129. Onderdonk AB. Host-microbe interactions: virulence mechanisms of bacterial pathogens. Science. 1988 Jun 3; 240(4857):1352-60.
    View in: PubMed
  130. Onderdonk AB, Zamarchi GR, Rodriguez ML, Hirsch ML, Muñoz A, Kass EH. Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol. 1987 Dec; 53(12):2774-8.
    View in: PubMed
  131. Onderdonk AB, Zamarchi GR, Rodriguez ML, Hirsch ML, Muñoz A, Kass EH. Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol. 1987 Dec; 53(12):2779-84.
    View in: PubMed
  132. Onderdonk AB, Bronson R, Cisneros R. Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis. Infect Immun. 1987 Mar; 55(3):835-6.
    View in: PubMed
  133. Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol. 1986 Jul 1; 137(1):341-6.
    View in: PubMed
  134. Zaleznik DF, Zhang ZL, Onderdonk AB, Kasper DL. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. J Infect Dis. 1986 Jul; 154(1):40-6.
    View in: PubMed
  135. Onderdonk AB, Zamarchi GR, Walsh JA, Mellor RD, Muñoz A, Kass EH. Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl Environ Microbiol. 1986 Feb; 51(2):333-9.
    View in: PubMed
  136. Onderdonk AB. Experimental models for ulcerative colitis. Dig Dis Sci. 1985 Dec; 30(12 Suppl):40S-44S.
    View in: PubMed
  137. Notarnicola SM, Zamarchi GR, Onderdonk AB. Misidentification of mucoid variants of Staphylococcus aureus by standard laboratory techniques. J Clin Microbiol. 1985 Sep; 22(3):459-61.
    View in: PubMed
  138. Zaleznik DF, Finberg RW, Shapiro ME, Onderdonk AB, Kasper DL. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest. 1985 Mar; 75(3):1023-7.
    View in: PubMed
  139. Onderdonk AB. The carrageenan model for experimental ulcerative colitis. Prog Clin Biol Res. 1985; 186:237-45.
    View in: PubMed
  140. Onderdonk AB, Steeves RM, Cisneros RL, Bronson RT. Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect Immun. 1984 Oct; 46(1):64-7.
    View in: PubMed
  141. Onderdonk AB, Shapiro ME, Finberg RW, Zaleznik DF, Kasper DL. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S91-5.
    View in: PubMed
  142. Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lönngren J. Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S25-9.
    View in: PubMed
  143. Onderdonk AB, Cisneros RL, Bronson RT. Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect Immun. 1983 Nov; 42(2):783-8.
    View in: PubMed
  144. Brown JP, McGarraugh GV, Parkinson TM, Wingard RE, Onderdonk AB. A polymeric drug for treatment of inflammatory bowel disease. J Med Chem. 1983 Sep; 26(9):1300-7.
    View in: PubMed
  145. Cooperstock M, Riegle L, Woodruff CW, Onderdonk A. Influence of age, sex, and diet on asymptomatic colonization of infants with Clostridium difficile. J Clin Microbiol. 1983 May; 17(5):830-3.
    View in: PubMed
  146. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Immune T cells prevent bacteroides fragilis abscesses. Curr Surg. 1983 Mar-Apr; 40(2):123-6.
    View in: PubMed
  147. Beaucage CM, Onderdonk AB. Evaluation of a prereduced anaerobically sterilized medium (PRAS II) system for identification anaerobic microorganisms. J Clin Microbiol. 1982 Sep; 16(3):570-2.
    View in: PubMed
  148. Cooperstock MS, Steffen E, Yolken R, Onderdonk A. Clostridium difficile in normal infants and sudden infant death syndrome: an association with infant formula feeding. Pediatrics. 1982 Jul; 70(1):91-5.
    View in: PubMed
  149. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982 Apr 1; 155(4):1188-97.
    View in: PubMed
  150. Kasper DL, Onderdonk AB. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model. Scand J Infect Dis Suppl. 1982; 31:28-33.
    View in: PubMed
  151. Onderdonk AB, Markham RB, Zaleznik DF, Cisneros RL, Kasper DL. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest. 1982 Jan; 69(1):9-16.
    View in: PubMed
  152. Onderdonk AB, Brodasky TF, Bannister B. Comparative effects of clindamycin and clindamycin metabolites in the hamster model of antibiotic-associated colitis. J Antimicrob Chemother. 1981 Nov; 8(5):383-93.
    View in: PubMed
  153. Bartlett JG, Louie TJ, Gorbach SL, Onderdonk AB. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis. 1981 May-Jun; 3(3):535-42.
    View in: PubMed
  154. Onderdonk AB, Franklin ML, Cisneros RL. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun. 1981 Apr; 32(1):225-31.
    View in: PubMed
  155. Onderdonk A, Marshall B, Cisneros R, Levy SB. Competition between congenic Escherichia coli K-12 strains in vivo. Infect Immun. 1981 Apr; 32(1):74-9.
    View in: PubMed
  156. Onderdonk AB, Bartlett JG. The biological and clinical significance of Clostridium difficile. Crit Rev Clin Lab Sci. 1981; 13(3):161-72.
    View in: PubMed
  157. Kasper DL, Onderdonk AB, Reinap BG, Linberg AA. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. J Infect Dis. 1980 Nov; 142(5):750-6.
    View in: PubMed
  158. Levy SB, Marshall B, Rowse-Eagle D, Onderdonk A. Survival of Escherichia coli host-vector systems in the mammalian intestine. Science. 1980 Jul 18; 209(4454):391-4.
    View in: PubMed
  159. Joiner KA, Gelfand JA, Onderdonk AB, Bartlett JG, Gorbach SL. Host factors in the formation of abscesses. J Infect Dis. 1980 Jul; 142(1):40-9.
    View in: PubMed
  160. Onderdonk AB, Cisneros RL, Bartlett JG. Clostridium difficile in gnotobiotic mice. Infect Immun. 1980 Apr; 28(1):277-82.
    View in: PubMed
  161. Zavistoski J, Dzink J, Onderdonk A, Bartlett J. Quantitative bacteriology of endodontic infections. Oral Surg Oral Med Oral Pathol. 1980 Feb; 49(2):171-4.
    View in: PubMed
  162. Joiner KA, Onderdonk AB, Gelfand JA, Bartlett JG, Gorbach SL. A quantitative model for subcutaneous abscess formation in mice. Br J Exp Pathol. 1980 Feb; 61(1):97-107.
    View in: PubMed
  163. Kasper DL, Onderdonk AB, Crabb J, Bartlett JG. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis. 1979 Nov; 140(5):724-31.
    View in: PubMed
  164. Onderdonk AB, Lowe BR, Bartlett JG. Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation. Appl Environ Microbiol. 1979 Oct; 38(4):637-41.
    View in: PubMed
  165. Kasper DL, Onderdonk AB, Polk BF, Bartlett JG. Surface antigens as virulence factors in infection with Bacteroides fragilis. Rev Infect Dis. 1979 Mar-Apr; 1(2):278-90.
    View in: PubMed
  166. Bartlett JG, Onderdonk AB. Virulence factors of anaerobic bacteria: summary of the symposium. Rev Infect Dis. 1979 Mar-Apr; 1(2):398-400.
    View in: PubMed
  167. Mansheim BJ, Onderdonk AB, Kasper DL. Immunochemical characterization of surface antigens of Bacteroides melaninogenicus. Rev Infect Dis. 1979 Mar-Apr; 1(2):263-77.
    View in: PubMed
  168. Onderdonk AB, Kasper DL, Mansheim BJ, Louie TJ, Gorbach SL, Bartlett JG. Experimental animal models for anaerobic infections. Rev Infect Dis. 1979 Mar-Apr; 1(2):291-301.
    View in: PubMed
  169. Gorbach SL, Onderdonk A. Experimental animal models and human disease. Gastroenterology. 1979 Mar; 76(3):643-5.
    View in: PubMed
  170. Onderdonk AB, Louie TJ, Tally FP, Bartlett JG. Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis. J Antimicrob Chemother. 1979 Mar; 5(2):201-10.
    View in: PubMed
  171. Bartlett JG, Chang T, Taylor NS, Onderdonk AB. Colitis induced by Clostridium difficile. Rev Infect Dis. 1979 Mar-Apr; 1(2):370-8.
    View in: PubMed
  172. Onderdonk AB, Bartlett JG. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr. 1979 Jan; 32(1):258-65.
    View in: PubMed
  173. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978 Nov; 75(5):778-82.
    View in: PubMed
  174. Bartlett JG, Chang TW, Moon N, Onderdonk AB. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res. 1978 Sep; 39(9):1525-30.
    View in: PubMed
  175. Hammerschlag MR, Alpert S, Onderdonk AB, Thurston P, Drude E, McCormack WM, Bartlett JG. Anaerobic microflora of the vagina in children. Am J Obstet Gynecol. 1978 Aug 15; 131(8):853-6.
    View in: PubMed
  176. Chang TW, Onderdonk AB, Bartlett JG. Anion-exchange resins in antibiotic-associated colitis. Lancet. 1978 Jul 29; 2(8083):258-9.
    View in: PubMed
  177. Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL. A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg. 1978 Jul; 113(7):853-7.
    View in: PubMed
  178. Bartlett JG, Chang TW, Onderdonk AB. Comparison of five regimens for treatment of experimental clindamycin-associated colitis. J Infect Dis. 1978 Jul; 138(1):81-6.
    View in: PubMed
  179. Chang TW, Bartlett JG, Gorbach SL, Onderdonk AB. Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun. 1978 May; 20(2):526-9.
    View in: PubMed
  180. Bartlett JG, Moon NE, Goldstein PR, Goren B, Onderdonk AB, Polk BF. Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol. 1978 Mar 15; 130(6):658-61.
    View in: PubMed
  181. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9; 298(10):531-4.
    View in: PubMed
  182. Onderdonk AB, Moon NE, Kasper DL, Bartlett JG. Adherence of Bacteroides fragilis in vivo. Infect Immun. 1978 Mar; 19(3):1083-7.
    View in: PubMed
  183. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology. 1978 Mar; 74(3):521-6.
    View in: PubMed
  184. Bartlett JG, Chang TW, Onderdonk AB. Will the real Clostridium species responsible for antibiotic-associated colitis please step forward? Lancet. 1978 Feb 11; 1(8059):338.
    View in: PubMed
  185. Mansheim BJ, Onderdonk AB, Kasper DL. Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. J Immunol. 1978 Jan; 120(1):72-8.
    View in: PubMed
  186. Sheckman P, Onderdonk AB, Bartlett JG. Anaerobes in spontaneous peritonitis. Lancet. 1977 Dec 10; 2(8050):1223.
    View in: PubMed
  187. Kasper DL, Onderdonk AB, Bartlett JG. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation. J Infect Dis. 1977 Dec; 136(6):789-95.
    View in: PubMed
  188. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977 Nov; 136(5):701-5.
    View in: PubMed
  189. Onderdonk AB, Hermos JA, Bartlett JG. The role of the intestinal microflora in experimental colitis. Am J Clin Nutr. 1977 Nov; 30(11):1819-25.
    View in: PubMed
  190. Bartlett JG, Onderdonk AB, Cisneros RL. Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology. 1977 Oct; 73(4 Pt 1):772-6.
    View in: PubMed
  191. Onderdonk AB, Polk BF, Moon NE, Goren B, Bartlett JG. Methods for quantitative vaginal flora studies. Am J Obstet Gynecol. 1977 Aug 1; 128(7):777-81.
    View in: PubMed
  192. Bartlett JG, Onderdonk AB, Drude E, Goldstein C, Anderka M, Alpert S, McCormack WM. Quantitative bacteriology of the vaginal flora. J Infect Dis. 1977 Aug; 136(2):271-7.
    View in: PubMed
  193. Kasper DL, Hayes ME, Reinap BG, Craft FO, Onderdonk AB, Polk BF. Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis. 1977 Jul; 136(1):75-81.
    View in: PubMed
  194. Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis. 1977 Jul; 136(1):82-9.
    View in: PubMed
  195. Louie TJ, Onderdonk AB, Gorbach SL, Bartlett JG. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin. J Infect Dis. 1977 Mar; 135 Suppl:S18-22.
    View in: PubMed
  196. Gorbach SL, Mayhew JW, Bartlett JG, Thadepalli H, Onderdonk AB. Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest. 1976 Feb; 57(2):478-84.
    View in: PubMed
  197. Onderdonk AB, Johnston J, Mayhew JW, Gorbach SL. Effect of dissolved oxygen and Eh and Bacteroides fragilis during continuous culture. Appl Environ Microbiol. 1976 Feb; 31(2):168-72.
    View in: PubMed
  198. Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL. Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976 Jan; 13(1):22-6.
    View in: PubMed
  199. Weinstein WM, Onderdonk AB, Bartlett JG, Louie TJ, Gorbach SL. Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis. 1975 Sep; 132(3):282-6.
    View in: PubMed
  200. Mayhew JW, Onderdonk AB, Gorbach SL. Effects of time and growth media on short-chain fatty acid production by Bacteroides fragilis. Appl Microbiol. 1975 Apr; 29(4):472-5.
    View in: PubMed
  201. Bartlett JG, Bustetter LA, Gorbach SL, Onderdonk AB. Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora. Antimicrob Agents Chemother. 1975 Jan; 7(1):55-7.
    View in: PubMed
  202. Weinstein WM, Onderdonk AB, Bartlett JG, Gorbach SL. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun. 1974 Dec; 10(6):1250-5.
    View in: PubMed
  203. Onderdonk AB, Weinstein WM, Sullivan NM, Bartlett JG, Gorbach SL. Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun. 1974 Dec; 10(6):1256-9.
    View in: PubMed
  204. Rubinstein E, Onderdonk AB, Rahal JJ. Peritonsillar infection and bacteremia caused by Fusobacterium gonidiaformans. J Pediatr. 1974 Nov; 85(5):673-5.
    View in: PubMed
  205. Maier BR, Onderdonk AB, Baskett RC, Hentges DJ. Shigella, indigenous flora interactions in mice. Am J Clin Nutr. 1972 Dec; 25(12):1433-40.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Onderdonk's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_